Ensysce Biosciences (ENSC) Operating Income (2018 - 2025)
Ensysce Biosciences (ENSC) posted Operating Income of -$3.74 million for Q3 2025, compared with $644,746 a year earlier.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Operating Income (2018 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Operating Income at Ensysce Biosciences was -$11.04 million; for FY2024, it was -$6.73 million.
- In prior years, Ensysce Biosciences' Operating Income was -$10.72 million in FY2023, -$24.22 million in FY2022, -$19.87 million in FY2021 and -$1.61 million in FY2020.
- The Q3 2025 figure stands as the lowest quarterly Operating Income since Q4 2022.
- According to Business Quant data, Operating Income for the three prior quarters was -$1.75 million (Q2 2025), -$1.97 million (Q1 2025) and -$3.58 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Ensysce Biosciences | 901,219.67 | -10.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -3.74 Mn |
| Jun 30, 2025 | -1.75 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Dec 31, 2024 | -3.58 Mn |
| Sep 30, 2024 | 644,746.00 |
| Jun 30, 2024 | -1.96 Mn |
| Mar 31, 2024 | -1.84 Mn |
| Dec 31, 2023 | -3.16 Mn |
| Sep 30, 2023 | -2.71 Mn |
| Jun 30, 2023 | -2.29 Mn |
| Mar 31, 2023 | -2.56 Mn |
| Dec 31, 2022 | -6.20 Mn |
| Sep 30, 2022 | -6.16 Mn |
| Jun 30, 2022 | -7.06 Mn |
| Mar 31, 2022 | -4.80 Mn |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | -16.89 Mn |
| Jun 30, 2021 | -412,617.00 |
| Mar 31, 2021 | -524,273.00 |
| Dec 31, 2020 | -1.09 Mn |
API Access
Ensysce Biosciences Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();